Dr. Atul Ambekar

2. Name: ATUL AMBEKAR

3. Designation: Professor

4. Qualifications :- MBBS, MD

5. Email ID- This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it.

6. Field of Interest:

• Public Health Issues related to Alcohol and Drug Use

• Opioid Substitution Therapy (OST) and Harm Reduction

• Training and human resource development

• Gender and drug use

• Drug Policies and Programs

• Epidemiology of drug use

• Community based research to facilitate access to services

• Use of Information and Communication Technology in addiction-related issues

7. Total number of publications till date: 185

8. Details of publications since 2010 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications):

PAPERS and ARTICLES (In Peer Reviewed Scientific Journals)

1. Teck JTW, Zlatkute G, Perez A, Dritschel H, Ghosh A, Potenza MN, Ambekar A, Ekhtiari H, Stein D, Khazaal Y, Arunogiri S, Torrens M, Ferri M, Galea-Singer S, Baldacchino A. Key implementation factors in telemedicine-delivered medications for opioid use disorder: a scoping review informed by normalisation process theory. Lancet Psychiatry. 2023 Jan;10(1):50-64. 

2. Forget P, Patullo C, Hill D, Ambekar A, Baldacchino A, Cata J, et al (2022). System-level policies on appropriate opioid use, a multi-stakeholder consensus. BMC Health Serv Res. 2022 Mar 12;22(1):329. doi: 10.1186/s12913-022-07696-x

3. Ambekar A (2022). Decriminalisation of drug use in India: A long overdue legal reform (editorial). Ind J Soc Psy. 2022, 38(3): 209-212. DOI: 10.4103/ijsp.ijsp_183_22

4. Ambekar A, Gautam M, Matcheswalla Y, Kar S, Kadam K (2022). Medicolegal Issues with Reference to NDPS and MHCA in Management and Rehabilitation of Persons with Substance Use Disorders. Indian J Psychiatry 2022 Mar;64(Suppl 1):S146-S153. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_724_21

5. Quraishi R, Varshney M, Rao RV, Ambekar A (2022). Evaluation of alcohol use pattern among OST patients using alcohol biomarkers: Report from community clinics in India. Indian J Psychiatry 2022 May-Jun;64(3):312-315

6. Singh R, Gupta R, Grover T, Ambekar A, Jain R, Vaswani M, Mishra A, Sharma A. Role of the Serotonin and GABAA Receptor Gene Polymorphisms in patients with Alcohol Dependence. Asian J Psychiatry,  2022 Nov 12;80:103326. doi: 10.1016/j.ajp.2022.103326.

7. Quraishi R, Sarkar S, Parmar A, Jain R, Das BK, Ambekar A (2022). Exploring the clinical variables among drug-dependent HIV-Positive patients: Implications for treatment strategies. Indian J Public Health 2022 Jul-Sep;66(3):331-333.

8. Choudhary N, Singh S, Rathore P, Ambekar A, Bhatnagar S (2021). Opioid Use Disorders among patients on long-term morphine for management for chronic cancer pain: A pilot study from a tertiary palliative care facility. Indian Journal of Palliative Care, 27(2); 264-268

9. Saini R, Parmar A, Rao R, Mishra AK, Ambekar A, Agrawal A (2021). Psychiatric and Substance Use Comorbidities among People who Inject Drugs in India: A Cross-Sectional, Community-Based Study. World Soc Psychiatry 2021;3:195-202.

10. Singh A, Rao R, Chatterjee B, Mishra AK, Kaloiya G, Ambekar A (2021). Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study, Asian Journal of Psychiatry, 61, 102697, https://doi.org/10.1016/j.ajp.2021.102697

11. Singh et al (India State-Level Disease Burden Initiative Neurological Disorders Collaborators) (2021). The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019. The Lancet Global Health, https://doi.org/10.1016/S2214-109X(21)00164-9

12. Schaub MP, Tiburcio M, Martínez-Vélez N, Ambekar A, Bhad R, Wenger A, Baumgartner C, Padruchny D, Osipchik S, Poznyak V, Rekve D, Landi Moraes F, Monezi Andrade AL, Oliveira Souza-Formigoni ML; WHO E-Health Project On Alcohol And Health Investigators Group (2021).  The Effectiveness of a Web-Based Self-Help Program to Reduce Alcohol Use Among Adults With Drinking Patterns Considered Harmful, Hazardous, or Suggestive of Dependence in Four Low- and Middle-Income Countries: Randomized Controlled Trial. J Med Internet Res. 2021 Aug 27;23(8):e21686. doi: 10.2196/21686.

13. Quraishi R, Sharma J, Jain R, Ambekar A (2021). Influence of catechol‑O‑methyltransferase enzyme gene polymorphism on alcohol and tobacco consumption in North Indian treatment seeking population. Indian J Psychiatry 2021;63:240-4

14. Manomy PA, Yenamandra VK, Dabas G, Joshi P, Ambekar A, Sreenivas V, Sharma VK, Vatsa M, Ravindran S, Sethuraman (2021). Impact of a psychodermatological education package on the subjective distress, family burden, and quality of life among the primary caregivers of children affected with epidermolysis bullosa. Indian Dermatol Online J 2021;12:276-80.

15. Chawla N, Verma S, Ganesh R, Sarkar S & Ambekar A (2021). Sexual relationship, self-esteem, dysfunction, and sexual satisfaction in treatment naïve men with heroin dependence. Journal of Psychoactive Drugs, doi.org/10.1080/02791072.2020.1870779

16. Castro‐Calvo, J., King, D. L., Stein, D. J., Brand, M., Carmi, L., Chamberlain, S. R., Demetrovics, Z., Fineberg, N. A., Rumpf, H.‐J., Yücel, M., Achab, S., Ambekar, A., Bahar, N., Blaszczynski, A., Bowden‐Jones, H., Carbonell, X., Chan, E. M. L., Ko, C.‐H., de Timary, P., Dufour, M., Grall‐Bronnec, M., Lee, H. K., Higuchi, S., Jimenez‐Murcia, S., Király, O., Kuss, D. J., Long, J., Müller, A., Pallanti, S., Potenza, M. N., Rahimi‐Movaghar, A., Saunders, J. B., Schimmenti, A., Lee, S.‐Y., Siste, K., Spritzer, D. T., Starcevic, V., Weinstein, A. M., Wölfling, K., and Billieux, J. (2021) Expert appraisal of criteria for assessing gaming disorder: An international Delphi study. Addiction, https://doi.org/10.1111/add.15411.

17. Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A; ISAM-PPIG Global Survey Consortium, Potenza MN, Ekhtiari H, Baldacchino AM (2021). Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Front Psychiatry. 2021 Apr 29;12:639393. doi: 10.3389/fpsyt.2021.639393. PMID: 34025471; PMCID: PMC8135096.

18. Farhoudian A, Radfar SR, Mohaddes Ardabili H, Rafei P, Ebrahimi M, Khojasteh Zonoozi A, De Jong CAJ, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Hansen H, Brady KT; ISAM Global Survey Consortium (ISAM-GSC), Potenza MN, Baldacchino AM, Ekhtiari H (2021). A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic. Front Psychiatry. 2021 Aug 6;12:646206. doi: 10.3389/fpsyt.2021.646206. PMID: 34421664; PMCID: PMC8377291.

19. Mohan, A., & Ambekar, A. (2020). Telepsychiatry and Addiction Treatment. Indian Journal of Psychological Medicine, 42(5_suppl), 52S-56S. https://doi.org/10.1177/0253717620958169

20. Sartaj D, Krishnan V, Rao R, Ambekar A, Dhingra N, Sharan P. (2020). Mental illnesses and related vulnerabilities in the Hijra community: A cross-sectional study from India. Int J Soc Psychiatry. 2020 Aug 20:20764020950775. doi: 10.1177/0020764020950775.

21. Gupta R, Grover S, Basu A, Krishnan V, Tripathi A, Subramanyam A, Nischal A, Hussain A, Mehra A, Ambekar A, Saha G, Mishra KK, Bathla M, Jagiwala M, Manjunatha N, Nebhinani N, Gaur N, Kumar N, Dalal PK, Kumar P, Midha PK, Daga R, Tikka SK, Praharaj SK, Goyal SK, Kanchan S, Sarkar S, Das S, Sarkhel S, Padhy SK, Sahoo S, Satyanarayana Rao TS, Dubey V, Menon V, Chhabra V, Lahan V, Avasthi A (2020). Changes in sleep pattern and sleep quality during COVID-19 lockdown. Indian J Psychiatry. 2020 Jul-Aug;62(4):370-378. doi: 10.4103/psychiatry.IndianJPsychiatry_523_20

22. Grover T, Gupta R, Arora G, Bal CS, Ambekar A, Basu Ray S, Vaswani M, Sharma A (2020).Dopamine transporter availability in alcohol and opioid dependent subjects - a ^99m Tc-TRODAT-1SPECT imaging and genetic association study. Psychiatry Res Neuroimaging. 2020 Sep 10;305:111187. doi: 10.1016/j.pscychresns.2020.111187

23. Dhagudu, N.K., Ambekar, A., Agrawal, A., Rao, R., Mishra, A.K., Jain, R. and Singh, S (2020). Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects. Drug Alcohol Rev. 2020; 39: 595-603 doi:10.1111/dar.13057

24. Sagar R et al (India State-Level Disease Burden Initiative Mental Disorders Collaborators) (2020). The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990–2017, The Lancet Psychiatry; 7 (2): 148-161

25. Rao R, Panda U, Gupta SK, Ambekar A, Gupta S, Agrawal A (2020). Portrayal of alcohol in Bollywood movies: A mixed methods study. Indian J Psychiatry, 62(2): 159-166

26. Goyal SG, Ambekar A, Jain R, Mehta M, Mishra AK (2020). Intravenous buprenorphine does not impair psychomotor and cognitive functioning in opioid-dependent patients using oral dextropropoxyphene: A randomized, double-blind, crossover study. J Mental Health Hum Behav 2020;25:45-52

27. Chawla N, Verma S, Sarkar S, Ambekar A (2020). Assessment of sexual behavior among patients seeking treatment for opioid dependence and their knowledge and attitude about high-risk sexual behavior: A cross-sectional observational study. Indian J Soc Psychiatry 2020;36:29-36

28. Vishwakarma A, Tarwani J, Chawla N, Dayal P, Agrawal A, Mandal P & Ambekar A (2020) Mephentermine dependence with induced psychosis: a series of two cases, Journal of Substance Use, 25:6, 569-571, DOI: 10.1080/14659891.2020.1749949

29. Rao R, Gupta SK, Swaminathan P, Gupta V, Dhawan A, Agrawal A & Ambekar A (2020) Predictors of long-term retention on opioid agonist treatment with buprenorphine: a 6-year, community-based retrospective cohort study in India, Journal of Substance Use, 25:5, 489-494, DOI: 10.1080/14659891.2020.1736666

30. Gupta S, Lal R, Ambekar A, Mishra AK, Rao R (2020). The pattern of alcohol use and its relationship with consequences among problem alcohol users: A community-based cross-sectional study from India. Indian J Psychiatry. 2020;62(2):152‐158. doi:10.4103/psychiatry.IndianJPsychiatry_194_19

31. Srivastava P, Mehta M, Sagar R, Ambekar A. Smartteen- a computer assisted cognitive behavior therapy for Indian adolescents with depression- a pilot study. Asian J Psychiatr. 2020;50:101970. doi:10.1016/j.ajp.2020.101970

32. Dhawan A, Mishra AK, Ambekar A, Chatterjee B, Agrawal A, Bhargava R (2020). Estimating the size of substance using street children in Delhi using Respondent-Driven Sampling (RDS), Asian Journal of Psychiatry: 48 (2020) 101890

33. Ambekar A, Mishra A, Parmar A, Kumar R, Kumar M, Rao R, Agrawal A (2019), Are non-injecting opioid users at risk of transition to injecting drug use? A multi-site study from India Asian Journal of Psychaitry, 42:79-84.

34. Jyani G, Prinja S, Ambekar A, Bahuguna P, Kumar R (2019). Health impact and economic burden of alcohol consumption in India International Journal of Drug Policy, 69; 34-42

35. Kathiresan P, Ambekar A, Sarkar S. (2019). Opioid Substitution Treatment Using Buprenorphine for Management of Dependence on Natural Opioids: Case Series, Indian J Psychol Med 11;41(6):586-588

36. Sood A, Mishra A, Ambekar A (2019), Trends in alcohol consumption and expenditure: Analysis of household data from nationally representative sample from India, Asian Journal of Psychaitry, 22;40:116-123.

37. Saini R, Rao R, Parmar A, Mishra AK, Ambekar A, Agrawal A, Dhingra N. (2019), Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugs in India: A community-based study.Drug Alcohol Rev.. doi: 10.1111/dar.13016.

38. Jain R, Quraishi R, Verma A, Ambekar A. (2019). Development and clinical evaluation of a dried urine spot method for detection of morphine among opioid users. Indian J Pharmacol; 51(1):40-44.

39. Rao R, Varshney M, Singh S, Agrawal A, Ambekar A(2019), Mental Healthcare Act, 2017 and Addiction Treatment: Potential Pitfalls and Trepidations Indian J Psychiatry, 61(2); 208-212

40. Mandal P, Parmar A, Ambekar A, Dhawan A(2019), Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian Journal of Psychaitry22;41:17-19

41. Ambekar A, Rao R, Agrawal A, Kathiresan P (2019) Research on opioid substitution therapy in India: A brief, narrative review. Indian J Psychiatry; 60:265-70

42. Quraishi R, Varshney M, Singh A, Singh D, Kumar M, Rao R, Jain R, Ambekar A. (2019). Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study. Indian J Psychol Med. Nov 11;41(6):529-534.

43. Chattopadhyay A, Gupta S, Dayal P, Mandal P, Agrawal A, Ambekar A (2019). Butorphanol dependence in a health-care professional: A case report with narrative review. Journal of Substance Use, doi.org/10.1080/14659891.2019.1604839

44. Dandona R, Kumar GA, Dhaliwal RS, Naghavi M, Vos T, Shukla DK, Vijayakumar L, Gururaj G, Thakur JS, Ambekar A, Sagar R, Arora M, Bhardwaj D, Chakma JK, Dutta E, Furtado M, Glenn S, Hawley C, Johnson SC, Khanna T, Kutz M, Mountjoy-Venning WC, Muraleedharan P, Rangaswamy T, Varghese CM, Varghese M, Reddy KS, Murray CJL, Swaminathan S, Dandona L (2018). Gender differentials and state variations in suicide deaths in India: the Global Burden of Disease Study 1990-2016. Lancet Public Health.  Oct;3(10):e478-e489. doi: 10.1016/S2468-2667(18)30138-5.

45. Ambekar A, Mongia M, (2018). Planning research in psychosocial interventions. Indian Journal of Psychiatry; 60 (8): 575-582

46. Rumpf HJ, Achab S, Billieux J, Bowden-Jones H, Carragher N, Demetrovics Z, Higuchi S, King DL, Mann K, Potenza M, Saunders JB, Abbott M, Ambekar A, Aricak OT, Assanangkornchai S, Bahar N, Borges G, Brand M, Chan EM, Chung T, Derevensky J, Kashef AE, Farrell M, Fineberg NA, Gandin C, Gentile DA, Griffiths MD, Goudriaan AE, Grall-Bronnec M, Hao W, Hodgins DC, Ip P, Király O, Lee HK, Kuss D, Lemmens JS, Long J, Lopez-Fernandez O, Mihara S, Petry NM, Pontes HM, Rahimi-Movaghar A, Rehbein F, Rehm J, Scafato E, Sharma M, Spritzer D, Stein DJ, Tam P, Weinstein A, Wittchen HU, Wölfling K, Zullino D, Poznyak V (2018). Including gaming disorder in the ICD-11: The need to do so from a clinical and public health perspective. J Behav Addict.:1-6. doi: 10.1556/2006.7.2018.59.

47. Sahni S, Tickoo M, Gupta R, Vaswani M, Ambekar A, Grover T, Sharma A. (2018). Association of serotonin and GABA pathway gene polymorphisms with alcohol dependence: A preliminary study. Asian J Psychiatry. pii: S1876-2018(17)30466-5. doi: 10.1016/j.ajp.2018.04.023

48. Ambekar A, Parmar A, Mandal P & Therthani S. (2017) High proportion of pentazocine dependence among treatment-seeking female injecting drug users (FIDUs) in India: A distinct population? Journal of Substance Use. DOI: 10.1080/14659891.2017.1364306

49. Dandona L. et al, (India State-level Disease Burden Initiative Collaborators). (2017) Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. LANCET, DOI: http://dx.doi.org/10.1016/S0140-6736(17)32804-0

50. Ambekar A, Murthy P, Basu D, Rao GP & Mohan A. (2017) Challenges in the scale-up of Opioid Substitution Treatment (OST) in India (Guest Editorial), Indian Journal of Psychiatry;59:6-9

51. Dhawan A,Rao R, Ambekar A, Pusp A & Ray R. (2017) Treatment of substance use disorders through the government health facilities: Developments in the Drug De-addiction Programme of Ministry of Health and Family Welfare, Government of India Indian Journal of Psychiatry. DOI:10.4103/psychiatry.IndianJPsychiatry_19_17 

52. Gupta S, Lal R, Rao R, Mishra A K & Ambekar A. (2017) Pattern of alcohol use among problem alcohol users in a community-based setting in India: A cross-sectional study. Journal of Substance Use. DOI: 10.1080/14659891.2017.1366557

53. Schaub MP, Tiburcio M, Martinez N, Ambekar A, Balhara YPS, Wenger A, Andrade ALM, Padruchny D, Osipchik S, Gehring E, Poznyak V, Rekve D & Souza-Formigoni MLO, WHO e-health project on Alcohol and Health Investigators Group (2017) Alcohol e-Help: Study protocol for a Web-based self-help program to reduce alcohol use in adults with drinking patterns considered harmful, hazardous, or suggestive of dependence in middle-income countries. Addiction. doi: 10.1111/add.14034

54. Saunders J B, Hao W, Long J, King DL, Mann K, Fauth-Bühler M, Rumpf HJ, Bowden-Jones H, Rahimi-Movaghar A, Chung T, Chan E, Bahar N, Achab S, Lee HK, Potenza M, Petry N, Spritzer D, Ambekar A, Derevensky J, Griffiths MD, Pontes HM, Kuss D, Higuchi S, Mihara S, Assangangkornchai S, Sharma M, Kashef A E, Ip P, Farrell M, Scafato E, Carragher N & Poznyak V. (2017) Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention J Behav Addict:1-9. doi: 10.1556/2006.6.2017.039

55. Singh R, Grover T, Gupta R, Ambekar A, Jain R and Sharma A. (2017) An Association Study of the COMT and GABA Gene Variants with Alcohol Dependence. J Addict Res Ther, 8:6 DOI: 10.4172/2155-6105.1000350

56. Gupta R, Grover T, Ambekar A, Singh R, Vaswani M and Sharma A. (2017) An Association Study on the Glutamate Pathway GRIN2A Gene Polymorphisms with Heroin Dependence. J Addict Res Ther, 8:6 DOI: 10.4172/2155-6105.1000348

57. Qureshi R, Jain R, Ambekar A & Mishra AK. (2017) Association of ankyrin repeats & kinase domain containing 1 (ANKK1) polymorphism with co-morbid alcohol and nicotine dependence: A pilot study from a tertiary care treatment center in North India. Indian Journal of Medical Research, (145); 33-38

58. Gupta SK, Ambekar A, Dhawan A & Mehta M (2017). Personality profile of alcohol and injecting opioid users: A comparative study from India, Asian Journal of Psychatry, 25: 142-146

59. Mandal P, Parmar A, Therthani S & Atul Ambekar (2016). Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment center, Journal of Substance Use, DOI: 10.1080/14659891.2016.1217092

60. Kuppili PP, Bhad R, Rao R, Dayal P & Ambekar A, (2016)The mis-adventurous use of prescription opioids in chronic non-cancer pain, National Medical Journal of India DOI: 10.3109/14659891.2015.1040092

61. Rao R, Ambekar A, Agrawal A, Pawar AK, Mishra AK & Khandelwal S. (2016) Evaluation of a five-day training programme on opioid substitution therapy in India, Drugs: Education, Prevention and Policy: DOI: 10.3109/09687637.2016.1167166

62. Rao R, Mandal P, Gupta R, Ramashankar P, Mishra AK, Ambekar A, Jhanjee S & Dhawan A. (2015) Factors affecting drug use during incarceration: a cross-sectional study of opioid-dependent persons from India, Journal of Substance Abuse Treatment: DOI:10.1016/j.jsat.2015.08.009

63. Bhad R, Dayal P, Kumar S & Ambekar A, (2015) The drug ketamine: a double edged sword for mental health professionals J Subst Use; DOI: 10.3109/14659891.2015.1040092

64. Varshney M, Ambekar A, Lal R, Yadav D, Rao R & Mishra AK, (2015) Brief Interventions for harmful alcohol use in opioid-dependent patients on maintenance treatment with buprenorphine: A prospective study from India, Addictive Disorders and Their Treatment,: doi: 10.1097/ADT.0000000000000076

65. Ambekar A, Rao R, Agrawal A, Mishra AK, Kishore K, Mukherjee D & Albertin C, (2015) Pattern of drug use and associated behaviours among female injecting drug users from northeast India: a multi-centric, cross-sectional, comparative study, Substance Use and Misuse,: 50:10, 1332-1340; DOI: 10.3109/10826084.2015.101313

66. Prakash S, Ambekar A & Dayal P, (2015) Occasional alcohol use, relapse to opioids and the role of disulfiram, Journal of Substance Use,DOI: 10.3109 / 14659891. 2015. 1029024

67. Ramdurg S, Ambekar A & Lal R. (2015) Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence. Ind Psychiatry J;24:29-34

68. Dhawan A, Chopra A, Ambekar A & Ray R. (2015) Treatment seeking behavior of inhalant using street children: Are we prepared to meet their treatment needs. Indian J Psychol Med;37:282-7

69. Ambekar A, Rao R, Mishra AK & Agrawal A, (2014) Type of opioids injected: Does it matter? A multicentric cross-sectional study of people who inject drugs, Drug Alcohol Rev 34: 97-104. doi: 10.1111/dar.12208

70. Gupta SK, Ambekar A, Dhawan A & Mehta M, (2014) Psychosocial factors associated with HIV-related high-risk injection behavior among people who inject drugs; 19 (2): 62-68

71. Bhad R, Ambekar A, and Dayal P, The lizard: an unconventional psychoactive substance?, Journal of Substance Use, Early Online: 1–2, DOI: 10.3109/14659891.2014.987836

72. Goyal S, Ambekar A & Ray R. Jul - Sep 2014 Ketamine Dependence in an Anesthesiologist: An Occupational Hazard? Indian Journal of Psychological Medicine,; Vol 36; 3

73. Pal A, Ambekar A & Bera SC, (2014) Pharmacovigilance in psychiatry: time to take notice Journal of Drug Discovery and Therapeutics, 2 (20), 38-39

74. Ambekar A, Rao R, Pun A, Kumar S & Kishore K (2013), The trajectory of Methadone Maintenance Treatment in Nepal, International Journal of Drug Policy 2013 Jul 8. doi:pii: S0955-3959(13)00094-7. 10.1016/j.drugpo.2013.06.001

75. Ambekar A, Rao R, Agrawal A (2013). India’s National Narcotic Drugs and Psychotropic Substances Policy 2012: A 20th Century Document in 21st Century. International Journal of Drug Policy 2013 Jul;24(4):374-5

76. Rao R, Agrawal A, Kishore K & Ambekar A (2013). Delivery models of opioid agonist maintenance treatment in South Asia: A good beginning. Bulletin of the World Health Organisation, Volume 91, Number 2, February 2013

77. Prasad P, Ambekar A & Vaswani M,(2013) Case–control association analysis of Dopamine receptor polymorphisms in alcohol dependence: a pilot study in Indian males, BMC Research Notes, 6:418

78. Quraishi R, Jain R & Ambekar A (2013), The Use of Dried Blood Spot Samples in Screening Drugs of Abuse Pharmacology & Pharmacy,4 (2); 152

79. Ambekar A & Pawar A, (2012) Low Dead-Space Syringes for HIV prevention among people who inject drugs: Interesting, but a much stronger case is required. International Journal of Drug Policy. pii: S0955-3959(12)00149-1. doi: 10.1016/j.drugpo.2012.09.009.

80. Singh RR & Ambekar A, (2012) Opioid substitution treatment in a public health setting: A collaboration between hospitals and NGOs in the Punjab. International Journal of Drug Policy, 23; 169– 171

81. Rao R, Ambekar A, Yadav S, Sethi H & Dhawan A, (2011)Slow-release oral morphine as a maintenance agent in opioid dependence syndrome: an exploratory study from India Journal of Substance Use; Early Online:1–7

82. Larance B, Ambekar A, Azim T, Murthy P, Panda S, Degenhardt L & Mathers B,(2011) The availability, diversion and injection of pharmaceutical opioids in South Asia, Drug Alcohol Rev. May;30(3):246-54.

83. Ramdurg S, Ambekar A & Lal R.(2011) Sexual Dysfunction among Male Patients Receiving Buprenorphine and Naltrexone Maintenance Therapy for Opioid Dependence J Sex Med. Mar 2. doi: 10.1111

84. Sood M & Ambekar A,(2011) Giving ‘fresh fruit juice’ to patient as a metaphor for giving care by family members / care takers. National Medical Journal of India, 24 (6): 375

85. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A & Strathdee SA, (2010) HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, LANCET, 375(9719)  1014-1028; DOI:10.1016/S0140-6736(10)60232-2

86. Prasad P, Ambekar A & Vaswani M, (2010) Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study, BMC Med Genet. 11;11:24
    

BOOKS AND MONOGRAPHS (AUTHORED / EDITED): Training Manuals / Resource Materials

1. National Drug Law Enforcement Agency (2021) [lead authors: Ambekar A & Kedia S]. Standard Policy and Practice Guidelines for NDLEA counselling centres. Lagos: United Nations Office on Drugs and Crime and National Drug Law Enforcement Agency (NDLEA), Government of Nigeria

2. Ambekar A & Mohan A (2019). Guidelines:Treatment of Opioid Dependence using Opioid Agonists (Buprenorphine),with focus on operational procedures. Gurugram:Indian Psychiatric Society

3. Ambekar A et al (2018)Dealing with Substance Abuse (Block 1), MCFTE-003, Substance Abuse Counselling and Therapy, New Delhi: Indira Gandhi National Open University

4. Ambekar A et al (2018) Therapeutic Interventions (Block 2), MCFTE-003, Substance Abuse Counselling and Therapy. New Delhi: Indira Gandhi National Open University

5. Ambekar A, Rao R & Agrawal A. (2017). Methadone Maintenance Treatment under National AIDS Control Programme: Training Manual. New Delhi: National AIDS Control Organisation and Emmanuelle Hospital Association

6. Rao R, Ambekar A & Agrawal A. (2017). Methadone Maintenance Treatment under National AIDS Control Programme: Clinical Practice Guidelines. New Delhi: National AIDS Control Organisation and Emmanuelle Hospital Association

7. Mohan A, Ambekar A, Basu D, Narayanan D, Rao GP, Saha G, Kumar MS, Kumar P, Murthy P, Singh RKL, Gupta R, Nagpal R & Rao TSS, (2017). Buprenorphine as OST. Opioid Substitution Therapy (OST) Using Buprenorphine. IPS-IAPP Task Force Recommendation for Organizing, Implementing and Scaling up of OST in India (with particular reference to policy and legal issues). Chandigarh: Indian Association of Private Psychiatry, April 2017

8. Agrawal A, Kumar M, Rao R & Ambekar A (2015). QUALITY ASSURANCE IN IMPLEMENTATION OF HARM REDUCTION SERVICES: A field manual for supervising and mentoring Targeted Interventions and OST centres working with Injecting Drug Users and their spouses under the National AIDS Control Programme. New Delhi: National AIDS Control Organisation, India.

9. Rao R, Agrawal A & Ambekar A (2014), Opioid Substitution Therapy under National AIDS Control Programme: Clinical Practice Guidelines for treatment with Buprenorphine. New Delhi: National AIDS Control Organisation, India.

10. Ambekar A, Rao R, Agrawal A, Ray R & Dhawan A (2013), Quality Assurance for OST Programmes: A Field Guide for Mentors, New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences and National AIDS Control Organisation, India

11. Ambekar A & Rao R (2013), Substance Use Disorders: A Manual for Facilitators,. New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences

12. Lal R & Ambekar A (Eds), (2013), Substance Use Disorders: A Manual for paramedical professionals, New Delhi: NDDTC, AIIMS, WHO-India and Ministry of Health and Family Welfare

13. Ambekar A (2012). Capacity Building Needs Assessment in the context of IDU Interventions in India. New Delhi: United Nations Office on Drugs and Crime (UNODC) Regional Office for South Asia, and National AIDS Control Organisation

14. Ray R, Dhawan A & Ambekar A (2011), Training on OST with Buprenorphine: A Training manual for service providers. New Delhi: National AIDS Control Organisation, India

15. Ambekar A (2010), Reaching out to female partners of Injecting Drug Users: A Training manual for service providers. New Delhi: United Nations Office on Drugs and Crime, Regional Office for South Asia

16. Ambekar A, Rao R, Kedia S & Mukherjee D (2011), A manual for counsellors in the context of Injecting Drug Use – Targeted Intervention. New Delhi: United Nations Office on Drugs and Crime (UNODC) Regional Office for South Asia, New Delhi and the Tata Institute of Social Sciences (TISS)

17. Tripathi B. M. & Ambekar A (Eds), (2010), Minimum Standards of Care for Government De-addiction Centres, New Delhi: NDDTC, AIIMS, WHO-India and Ministry of Health and Family Welfare

BOOKS AND MONOGRAPHS (AUTHORED / EDITED): Research reports

1. Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda RK on behalf of the group of investigators for the National Survey on Extent and Pattern of Substance Use in India (2019). Magnitude of Substance Use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India

2. Atul Ambekar, Ravindra Rao, Alok Agrawal, Ashwani Mishra, Rajesh Kumar, Manish Kumar (2016) Punjab Opioid Dependence Survey. New Delhi: SPYM and NDDTC, AIIMS

3. Atul Ambekar, Viswanathan Arumugam, Umesh Sharma, Rajkumar Raju, Shalini Singh (2014), Drug Use Patterns among Clients Receiving Services from Targeted Interventions for People Who Inject Drugs: Findings from Bihar, Haryana, Jammu and Uttarakhand, New Delhi: India HIV/AIDS Alliance, 2014.

4. Anju Dhawan, Ravindra Rao, Atul Ambekar, Anita Chopra, Raka Jain, Deepak Yadav, Rajat Ray, (2014). Methadone Maintenance Treatment in India: A Feasibility and Effectiveness Report. New Delhi: United Nations Office on Drugs and Crime (UNODC) Regional Office for South Asia

5. Atul Ambekar (2012), Factors Influencing the performance of Targeted Interventions among IDUs. New Delhi: United Nations Office on Drugs and Crime (UNODC) Regional Office for South Asia, and National AIDS Control Organisation, India

6. Atul Ambekar (2012), Association of Drug Use Pattern with vulnerability and service uptake among IDUs, New Delhi: United Nations Office on Drugs and Crime (UNODC) Regional Office for South Asia, and National AIDS Control Organisation

7. United Nations Office on Drugs and Crime (multiple contributors) (2012) National Drug Use Survey in Maldives. Male’: UNODC, Maldives Project Office

8. Atul Ambekar (2012), HIV Prevention among IDUs and their female sex partners – Implementation Gaps and Barriers: A Study in Punjab, Haryana and Chandigarh. New Delhi: United Nations Office on Drugs and Crime (UNODC) Regional Office for South Asia

9. Anne Bergenstrom, Dean Lewis, Jyoti Mehra, Kunal Kishore, M. Suresh Kumar, Atul Ambekar and Ravindra Rao (2010) IDU and HIV: India Country Advocacy Brief.Bangkok:United Nations Regional Task Force on Injecting Drug Use and HIV/AIDS for Asia and the Pacific, UNAIDS.

CHAPTERS IN BOOKS / MONOGRAPHS

1. Ambekar A, Singh S (2022). “Dealing with Drug Addiction”. In Chadda RK, Pratap S, Sood M, Deb KS (eds) Mental Health at Crossroads: Challenges and Solutions. New Delhi: White Falcon Publishing

2. Ambekar A (2021), “Challenges in managing substance use disorders during COVID19 pandemic”. In Bhattacharyya R, Dalui A, Bandhopadhyay T, Sen A (eds) Guidelines for managing mental health issues during COVID 19 pandemic. Kolkata: Indian Medical Association – Bengal State Branch

3. Ambekar A., Rao R., Agrawal A. (2021). “Contribution towards national policies and programs related to addiction treatment services during COVID-19 pandemic: An experiential account” (pp 70-74). In Chadda R, Sood M, Deep R (eds), COVID19 pandemic and Mental Health: Experiences of organizing services at a tertiary care healthcare institution. New Delhi: Dept. of Psychiatry and NDDTC, AIIMS, New Delhi

4. Ambekar A, George A (2020). “Integrating the biological basis and the pharmacotherapy of Alcohol dependence: Focus on current and potential interventions.” In Gupta N, Kumar P, Mohan A (eds) Recent Advances in Biological Psychiatry – Theme: Addiction Psychiatry (2^nd ed). Mumbai: Indian Association of Biological Psychiatry

5. Ambekar A, Mandal P (2020). “Substance related disorders” In Singh PK, Singh OP, Kumar V (eds) IPS Text book of Undergraduate Psychiatry. New Delhi: Jaypee brothers medical publishers

6. Qureshi R, Ambekar A (2018). “Genetics of Alcohol Use Disorders” in Bhuyan D (Ed). Psychiatry Update. Dibrugarh: Assam Medical College

7. Ambekar A, Chawla N (2018). “Cannabis: From Neurobiology to Policy” in Bhuyan D (Ed). Psychiatry Update. Dibrugarh: Assam Medical College

8. Dabholkar H, Ambekar A & Benegal V,(2017) “Psychiatric Emergencies in Substance Abuse” in Thara R, Vijayakumar L (eds), Emergencies in Psychiatry in Low and Middle Income countries, Edition - II, New York: Routledge

9. Qureshi R, Jain R & Ambekar A. (2017) “Dried Blood Spots for Testing Drugs of Misuse”, in Wolff K (Ed), Detection of Drug Misuse : Biomarkers, Analytical Advances and Interpretation, Cambridge: Royal Society of Chemistry

10. Ambekar A & Goyal S (2016), “Clinical Practice Guidelines for treatment of Amphetamine Type Stimulants”, in Basu D, Dalal PK (eds), Clinical Practice Guidelines on Newer and Emerging Addictive Disorders in India, New Delhi: Indian Psychiatric Society

11. Srivastava P, Mehta M, Ambekar A & Sagar R (2015), “Depression” in Mehta M, Sagar R (eds), A Practical Approach to Cognitive Behaviour Therapy for Adolescents, New Delhi: Springer India

12. Ambekar A & Pawar A (2015), “Epidemiology of Substance Use in India: Emerging insights”. Hyderabad: Souvenir of Annual National Conference of Indian Psychiatric Society, 2015 (ANCIPS-2015).

13. Ambekar A & Goyal S (2015), “Clinical Practice Guidelines for treatment of Opioid Use Disorders”, in Basu D, Dalal PK (eds), Handbook -Clinical Practice Guidelines for Substance Use Disorders, New Delhi: Indian Psychiatric Society

14. Ambekar A (2014), “Management of Substance Use in India: Where we are and where do we need to go?”. Souvenir of Annual Conference of Indian Psychiatric Society – East Zone, 2014 (CEZIPS-2014), Dibrugarh:Department of Psychiatry, Assam Medical College

15. Ambekar A & Deb KS , (2013). “Import of Narcotics for Clinical Trial Supplies”, in Kshirsagar N, Kulkarni T, Desai A, Shah J (eds), Regulatory requirements for Drug Development and Clinical Research, New Delhi: Indian Council of Medical Research (ICMR)

16. Ambekar A (2013), “Pharmacotherapy for opioid dependence”, in Rakesh Lal, Ramandeep Pattnayak (eds), Substance Use Disorders: Handbook for Physicians. New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences

17. Ambekar A & Goyal S (2013), “Methadone Maintenance Treatment” in Dhawan A, Jhanjhi S (eds) Manual for Long-term pharmacotherapy of alcohol and opiate dependence New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences

18. Ambekar A & Kattimani S (2013), Anti-craving medications for long-term treatment of alcohol dependence, in Dhawan A, Jhanjhi S (eds) Manual for Long-term pharmacotherapy of alcohol and opiate dependence . New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences

19. Dabholkar H, Ambekar A & Benegal V, “Psychiatric Emergencies in Substance Abuse” in Thara R, Vijayakumar L (eds), Emergencies in Psychiatry in Low and Middle Income countries, (2012), Manipal: Byword Books

9. Presentations made at scientific meetings/ conferences/ workshops (2017 onwards)

1. Opioid Substitution Treatment: Policy and legal considerations. Invited plenary presentation at the ADDICON 2022, Annual conference of Addiction Psychiatry Society of India (APSI), Bengaluru, 3 December 2022

2. Drugs and Children in the context of Right to a drug free childhood. Invited plenary presentation at the conference, “Children Matter” organized by the 4^th wave foundation and world federation against drugs, Thiruvananthapuram, 17 Nov 2022

3. Laws and policies related to addiction treatment. Invited plenary presentation at the Annual conference of Indian Association of Private Psychiatry - Haryana, Solan 12 November 2022

4. Overview of drug use and addiction. Invited plenary presentation at the Annual conference of Indian Association of Private Psychiatry - Haryana, Solan 11 November 2022

5. How to address substance use in Mental health programs? Panel discussion as a part of Mental Health Forum 2022, organized by the World Health Organization (Geneva), 10 Oct 2022

6. Challenges in the meaningful involvement of civil society in drug policies. Symposium presentation at ISAM 2022 global congress, Malta, 5 Oct 2022

7. ISAM-GEN Structure and Expert Contact Points: From Individuals to Addiction Societies and Treatment Centers. (With Preethy K). Symposium presentation at ISAM 2022 global congress, Malta, 4 Oct 2022

8. Time for India to End Its War on Drugs? Panel discussion by “Argumentative Indians”, (online), 25 Sep 2022

9. Treatment of Opioid Dependence: Policy and Legal Considerations. CME organized by the Hyderabad Psychiatric Society, Hyderabad, 24 Sep 2022

10. Understanding Drug Use (and how to deal with it?). Online Training on Drug Law Enforcement, organized by National Academy of Customs, Indirect Taxes and Narcotics (NACIN), Mumbai, 20 Sep 2022

11. Laws and Policies related to Addiction Psychiatry. NationalWebinar presented for the resident doctors of National Board of Examination (DNB-Psychiatry), 14 Sep 2022

12. Substance Use and Suicide. Invited lectureat the Annual National Conference of Society for Rural Mental Health, Solan, 10 Sep 2022

13. Drug Use in India: What role could police play?, Training program Police Officers, Delhi Police Academy New Delhi, 8 Sep 2022

14. Harm Reduction: Concept, Philosophy and application to Tobacco. Round table organized by the Policy Circle, New Delhi 4 Sep 2022

15. Harm Reduction: Opioid Substitution Therapy and Needle Exchange Programs for people who inject drugs. Training program for medical and paramedical staff at Delhi Prisons, New Delhi, 24 August 2022

16. SUBSTANCE USE DISORDERS & BIPOLAR DISORDER: Assessment & Management. Invited lecture in the Post Graduate Development Program of Indian Psychiatric Society – North Zone, Srinagar, 21 August 2022

17. Substance Use Disorders & their treatment: Situation in India. Invited presentation in the panel discussion on World Mental Health Report 2022, India International Centre, New Delhi, 12 August 2022

18. Long Acting pharmacological options for opioid dependence: Effectiveness and Ethics. Webinar organized by the Indian Association of Biological Psychiatry (IABP), 5 August 2022

19. Drug Addiction & its treatment: Situation in India. Invited lecture at the conference on “Drug trafficking and National security”, Narcotics Control Bureau, Chandigarh, 31 July 2022

20. Cannabis: The Changing Landscape of Perception and Policies. Invited lecture at GPsyCon 2022, Annual conference of Goa Psychiatric Society, Goa, 23 July 2022

21. Drug Addiction situation & responses in India: Focus on North-East. Invited lecture at North East Police Coordination Committee meeting organized by DG police, Tripura, Agartala, 22 July 2022

22. Nasha – Ek Bimari. Ilaaj hai zaroori. Panel discussion organised by the Public Health Dept., Govt. of Maharashtra and Indian Psychiatric Society, West Zone, Mumbai, 17 July 2022, online

23. Drug Addiction & Drug Laws: The interface. ‘Core Competence Conference on Knowledge, Skills & Perspective Development for Special Judges – NDPS Act’, Delhi Judicial Academy, New Delhi, 16 July 2022

24. Treatment of Opioid Dependence: Policy and Legal Issues. CME on addiction psychiatry organized by AIIMS, Bhubaneswar, 10 July 2022

25. Indo-Us Enhanced cooperation related to substance use prevention, treatment and rehabilitation. Presented on behalf of MoH&FW, Govt. of India at India-US Counter-Narcotics Working Group (CNWG), meeting; New Delhi, 7 July, 2022

26. Facts about drug use and addiction. E-SYMPOISUM on Trends in Narcotic Drugs Psychotropic Substances, organized by the Forensic Science laboratory, Govt of Delhi; 27 June 2022; online

27. Recent Policy Update in Decriminalisation of Drug Use.  CME - 'Recent Advances in Addiction Psychiatry’ organized by AIIMS Jodhpur; 26 June 2022, online

28. Substance Use: Government Policies and Laws.  Capacity Building Program for Govt. college teachers (Assistant professor level) of social sciences; NDDTC AIIMS; Ghaziabad, 18 June 2022 

29. Substance Abuse & Alcohol Addiction: Deciphering its Impact on the Mental Health of Adolescents & Young Adults. Panel discussion (webinar) organized by the Asia Society India; 25 May 2022, online

30. Magnitude of drug use in India & our drug policies. Panel discussion on the occasion of inauguration of National Resource Centre on NCDs; 28 April 2022; Thiuvalla, Kerala.

31. Epidemiological research on substance use in India. Lessons from the field. Webinar on ‘Innovations in Addictions Research in India’ organized by Sangath, Goa; 21 April 2022; online

32. Substance Use: Attitudes, Policies and Stigma in India. Annual Conference of American Society of Addiction Medicine (ASAM), 15 April 2022; online

33. Use of addictive substances: Myths and facts. World Health Day event for students and resident doctors at AIIMS, New Delhi, 7 April 2022; New Delhi

34. Brief Interventions for Tobacco and Alcohol use disorders. 7^th International Course on Public Health Approaches to Non-communicable Diseases (NCDs), organized by Centre for Community Medicine, AIIMS New Delhi in partnership with World NCD Federation and World Health Organization (WHO); 7 April 2022; New Delhi

35. NDPS Act and the Psychiatrist. Panel discussion moderated at the national CME during the Annual National Conference of Indian Psychiatric Society (ANCIPS); 24Mar 2022; Vishakhapatnam

36. Amendments in the NDPS Act. Panel discussion and workshop organized by the Department of Revenue, Min. of Finance, Government of India; 9 Mar 2022; New Delhi

37. Decriminalization of drug use- Need of the hour. CME organized by the Indian Psychiatric Society North Zone; 9 Feb 2022; Online

38. Drug Addiction among children. Training workshop organized by Narcotics Control Bureau (NCB), Govt of India and National Commission for protection of child rights (NCPCR); 8 Feb 2022; Online

39. Magnitude of drug use in India. Training workshop organized by Narcotics Control Bureau (NCB), Govt of India and National Commission for protection of child rights (NCPCR); 8 Feb 2022; Online

40. The International Scheduling System for Narcotic Drugs & Psychotropic Substances: Implications for South Asia. Conference of SAARC Psychiatric Federation (SPF), Kolkata, 18 December 2021

41. Newer Pharmacotherapies for treatment of opioid dependence: Evidence and Ethics. Annual meeting of Indonesian Psychiatric Association, 5 December 2021

42. The International Scheduling System for Narcotic Drugs & Psychotropic Substances: Does It Need an Overhaul?. Plenary lecture in ISAM 2021 Global congress, 21 Nov 2021

43. India: COVID19, Lockdown & Addiction Treatment. Symposium in ISAM 2021 Global congress 21 Nov 2021

44. Newer Pharmacotherapies for treatment of opioid dependence: A Critique. Annual conference of East Zone Indian Psychiatric Society 12 Nov 2021

45. Management of Alcohol Use Disorders in medical settings. Conference of IMA West Zone, 12 Oct 2021

46. Leveraging Information Technology for capacity building in Addiction Treatment. CME organized by IPS West Zone 9 Oct 2021

47. Newer Pharmacotherapies for treatment of opioid dependence: Evidence and Ethics. Annual conference by UP IPS, 25 Sep 2021

48. E-Health Screening & Brief Interventions: Implications for LAMI countries. Plenary lecture in INEBRIA conference, 24 Sep 2021

49. The Genesis of APSI. Symposium presented in WASP 2021, 16 Sep 2021

50. ICD – 11 classification for substance use and addictive behaviors. National CME organized by PGIMER Chandigarh, 15 Sep 2021

51. Opioid Dependence: An overview of management. National Workshop organized by Dept of Addiction Medicine, LGBRIMH, Tezpur, 4 Sep 2021

52. Substance Use Disorders: A public health concern. Guest lecture (online) delivered for the faculty and students from Armed Forces Medical College (AFMC), Pune, 12 August 2021

53. Facts about drugs and addiction. Lecture delivered to the senior officials on Sashastra Seema Bal (SSB), on the occasion of International Day against Drug Abuse and Illicit Trafficking, 30 June 2021

54. National Policies and Programmes on treatment of substance use disorders. Webinar organized by the Nursing Division, Ministry of Health and Family Welfare, Govt. of India on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021

55. The International Framework for Drug Control. Webinar organized by the Central Institute of Psychiatry (CIP) on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021

56. Laws and Policies related to Addiction Psychiatry. Online CME organized by AIIMS, Nagpur on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021

57. Opioid Agonist Treatment: Evidence for effectiveness in Opioid Use Disorders. Webinar organized by the Institute of Mental Health and Neurosciences, GMC, Srinagar J&K, on the occasion of International Day against Drug Abuse and Illicit Trafficking, 25 June 2021

58. Why India does not have an overdose crisis (so far)? Workshop delivered (online) in the International conference ‘Let’s talk overdose’ organized by the University of British Columbia, Vancouver, Canada, 23 June 2021

59. India, COVID19 and Addictions. International conference on Technology Addiction, organized by Turkish Green Crescent Society, online, 2 June 2021

60. Cannabis: the changing landscape of perceptions and policies. CME of Indian Psychiatric Society – South Zone, online – 24 April 2021

61. Addiction treatment services duringCOVID19 in India. Side event during the CND meeting (virtual), organized by the International Doctors on Healthier Drug Policies (IDHDP) – 12 April 2021

62. Addictions To Cyberspace & Their Management. Delivered at CME organized by the Indian Psychiatric Society – West Zone, Online – 11 April 2021

63. Brief interventions and MET in substance use disorders. ‘Thursday Musings’ webinar series organized by the Indian Psychiatric Society – Odisha branch, 18 March 2021 

64. Treatment of Substance Use Disorders. National Webinar on ‘Dimensions of Social Defence & Linkages with SDGs’ organized by the FORE school of management, 24 February 2021

65. Epidemiology of Substance Use. PG Development program organized by the Indian Psychiatric Society – Central Zone, 20 February 2021

66. Drug Addiction: An overview and strategies for management. Forensic and Technical Course on Narcotic Drugs and Psychotropic Substances for Sri Lankan Police officers, organized by the Central Academy of Police Training, 12 February 2021

67. Newer Technologies for treatment of opioid dependence: Evidence and Ethics. Annual National conference of Indian Association of Biological Psychiatry, 7 February 2021

68. ICD-11 Disorder related to Substance Use and Addictive Behaviour: Field Trial India. National CME organized by the Addiction Psychiatry Society of India (APSI), 31 January 2021

69. Harm Reduction: Concept, Philosophy and application to Tobacco. Webinar organized by the Association for Harm Reduction Education and Research, 19 January 2021

70. Cannabis Policies: The Way forward. Webinar organized by Indian Psychiatric Society, West Bengal, 17 January 2021

71. Evidence Based Treatment of Cannabis Dependence. Webinar organized by the Behavioural and Neuroscience Academy of India, 5 January 2021

72. COVID19 pandemic: Impact on Addiction Psychiatry. Annual National Conference of Indian Association of Private Psychiatry, 5 December 2020

73. Opioid Use Epidemic in India: Changing Pattern and Policy Implications. Keynote address delivered in the ISAM Asia Regional conference, 5 December 2020

74. Medicolegal issues with reference to NDPS & MHCA in management of Substance Use Disorders. Webinar organized by Indian Psychiatric Society, 27 October 2020

75. Public health and addictive drugs: Laws and Policies: What works and What doesn’t. Webinar organized by Meghalaya legal services authority and Government of Meghalaya on Mental health day, 9 October 2020

76. SUBSTANCE USE IN NAGALAND. State level consultation organized by Kripa Foundation, Nagaland, 4 August 2020

77. Laws and Policies related to Addiction Psychiatry. Webinar organized by Kolkata Psychiatry Club and Indian Psychiatric Society, West Bengal. 26 July 2020

78. Opioid Substitution Treatment : An Overview. Webinar organized by Indian Psychiatric Society, Odisha, 26 July 2020

79. Benzodiazepine use disorders in clinical practice. Webinar organized by the Indian Psychiatric Society, Karnataka Chapter, 2 July 2020

80. India: COVID19, Lockdown and Addictions. Webinar organized by Govt. of NCT of Delhi, 26 June 2020

81. India: COVID19, Lockdown and Addictions. Webinar organized by International Society of Addiction Medicine, 20 May 2020

82. Services for Drug Use among youth. Moderated the Panel Discussion, during the Indo Scotland Mental Health Conclave, New Delhi, 29 January 2020

83. Alcohol: Evidence for impact of Prohibition. National Conference ‘From Neurons to Neighbourhood’, by Sun Pharma Research Foundation, New Delhi, 27 January 2010

84. Magnitude of drug use in India and the existing policy and program framework for response: A road map for evidence-informed drug supply control and demand reduction, Symposium deliveredat the Annual National Conference of Indian Psychiatric Society (ANCIPS), Kolkata, 24 January 2020

85. Behavioural Addiction: A Primer for Mental Health Professionals, workshop conducted at the National CME during the Annual National Conference of Indian Psychiatric Society (ANCIPS), Kolkata, 22 January 2020

86. Pharmaceutical drug addiction. Training workshop for Police officers from Sri Lanka, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 20 January 2020

87. Classification of Psychoactive Substances: Based on Science? CME of Addictive Disorder Specialty section, Indian Psychiatric Society, Mumbai, 5 January 2020

88. Substance Use Disorders: An Overview. Workshop for undergraduate Medicalstudents of Rajasthan, Jaipur, 21 December 2019

89. Opioid Substitution Treatment: An Overview. National Consultation on OST, Yangon, Myanmar, 11 December 2019

90. Long term pharmacotherapy for alcohol use disorders. CME of Indian Psychiatric Society, West Zone, Goa, 7 December 2019

91. Pharmaceutical drug use disorders. Training workshop for Drug Law Enforcement officers from Afghanistan, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 5 December 2019

92. Debate: OST is the most evidence-based, ethical and appropriate treatment for opioid dependence (For). PSCHIATRICKS, New Delhi, 24 November 2019

93. Drug Laws and Policies: International trends. Annual Conference of Indian Psychiatric Society, North Zone, Amritsar, 3 November 2019

94. Concept and Philosophy of Drug Harm Reduction: Application in India. Stakeholder consultation on substance use harm reduction, Knowledge Action Change, New Delhi, 17 October 2019

95. A Road map for evidence informed drug supply control response in India. Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong, 15 October 2019

96. Drug Use Situation in India. Conference on Comprehensive Approach to Combating Illicit Trafficking of Afghan Opiates and Drug Situation in North East, Imphal, 30 September 2019

97. Drug Policy responses in India. Asian Regional Forum Against Drugs, Kochi, 25 September 2019

98. Outpatient management of Opioid Dependence. Annual National Conference of Indian Association for Biological Psychiatry, Agra, 20 September 2019

99. Drug Testing: A new harm reduction intervention at the interface of Toxicology and Addiction Psychiatry. Conference of Indian Association of Medico Legal Experts and Medico Legal Conference Nepal, Kathmandu, 13 September 2019

100. Integrated Package Of Services For Injecting Drug Users. National consultation organized by NACO, Govt. of India, New Delhi, 3 September 2019

101. Size estimation of Injecting Drug Users in India. Meeting of Technical Experts organized by NACO, Govt. of India, 26 August 2019

102. Substance Use and Sexual Dysfunction. National Mid Term CME of Indian Psychiatric Society, Mysore, 10 August 2019

103. Substance Use situation in India: evidence-informed prevention strategies. National workshop on Substance Use Prevention for State Council of Education Research and Training (SCERTs), New Delhi, 2 August 2019

104. Drug Use in India: What role could police play?, Orientation program on National Action Plan for Police key coordinators, New Delhi, 18 June 2019

105. Preventing Substance Use: What Works, What doesn’t. AnnualCME of Indian Psychiatric Society – West Zone, Nashik, 27 April 2019

106. Magnitude of Substance Use in India. Regional Consultation on Drug Use organized by United Nations Office on Drugs and Crime, New Delhi, 24 April 2019

107. Epidemiology of Substance Use in India. CME of Society for Rural Mental Health, Hisar, 21 April 2019

108. National Drug Use Survey: “Magnitude of Substance Use in India”. Annual Meeting of Narcotics Coordinaton NARCORD, Ministry of Home Affairs, New Delhi 12 March 2019

109. Preventing Substance Use: What Works, What doesn’t. Annual Psychology Festival, Aryabhata College, Delhi University, New Delhi, 1 March 2019

110. Magnitude of Substance Use in India. National Conference of Principle Secretaries of State Governments, organized by MoSJE, Govt. of India, 26 February 2019

111. Drug Use situation in India. training programme for Drug Law Enforcement officers from NCB, National Academy of Customs, Indirect Tax and Narcotics (NACIN), New Delhi, 25 February 2019

112. Magnitude of Substance Use in India. Panel Discussion on ‘10 years of Drug Policy in Asia: How far we have come?’ New Delhi, 20 February 2019

113. Drug Abuse scenario in India, vulnerable population and treatment services. Interactive Workshop under National Action Plan for Drug Demand Reduction organized by the National Institute of Rural Development & Panchayati Raj, Hyderabad, 1 February 2019

114. Management of Opioid Dependence. CME update organized by the Jammu and Kashmir Psychiatric Society, Jammu, 18 January 2019

115. Drug Use and HIV: Interface with Law enforcement: National Consultation with Police Training Academies, Organized by NACO, Govt. of India, New Delhi, 10 January 2019

116. Opioid Pharmaceuticals: Policy and legal issues. Indian Pharmaceutical Congress, NOIDA, 22 December 2018

117. Policy and legal issues related to Opioid analgesics in palliative care and addiction treatment. Workshop “opioids in palliative care” organized by FDA, Punjab, Chandigarh, 18 Dec 2018

118. Preventing Substance Use: What Works, What Doesn’t. National CME of Preventive Psychiatry Section of Indian Psychiatric Society, Patna, 8 December 2018

119. Abuse of Pharmaceutical drugs in India. training programme for Drug Law Enforcement officers from Myanmar, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 6 December 2018

120. Opioid Substitution Treatment (OST) is the Best strategy for management of Opioid Use Disorders. (Debate – For). National Conference of Indian Association of Private Psychiatry (ANCIAPP), Hyderabad, 1 December 2018

121. Intervention Strategies for Alcohol Use Disorders. National Conference of Indian Society of Gastroentrology, Kochi, 30 November 2018

122. Drug Laws and Policies. What Works and What Doesn’t. Law Economics Policy Conference (LEPC 2018), organized by the National Institute of Public Finance and Policy (NIPFP), New Delhi, 27 November 2018

123. Addiction in North East: Opportunities, Challenges and the way forward. North East Health Care Leadership Summit 2018, Shillong, 29 October 2018

124. Mental Health Care Act (MHCA) 2017: Implications for Addiction Treatment in India. Annual Conference of Indian Psychiatric Society – Rajasthan State, Bikaner, 20 October 2018

125. Treatment of Opioid Dependence: Policy and Legal Issues. National conference of Society for Rural Mental Health, Karnal, 29 September 2018

126. Pharmaceutical drug use – South Asia, training programme for officers from Department of Narcotics Control, Bangladesh, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 26 September 2018

127. Drug Laws and Policies: Scientific arguments for criminalization and De-Criminalization. training programme for judiciary, Delhi Judicial Academy, 15 September 2018

128. Sleep and Opioids: Neurobiology and clinical aspects. Global Conference of Biological Psychiatry, Mumbai, 25 August 2018

129. Changing legal and policy scenario for drugs: Implications for Psychiatrists. Mid Tem CME of IPS East Zone, Dibrugarh, 18 August 2018

130. Cannabis: From Neurobiology to Policy. Mid Tem CME of IPS East Zone, Dibrugarh, 18 August 2018

131. Data collection and analysis for Drug Use Epidemiology: An overview. Training Programme on “Planning and Designing of large scale sample surveys” for officers of Indian Statistical Service, National Statistical Systems Training Academy (NSSTA), Greater Noida, 19 June 2018

132. Economic Cost (and benefit) of Scale-up of Opioid Substitution Treatment in National AIDS Control Program, India: Comparison of three scenarios. Conference of International Society for the Study of Drug Policy (ISSDP 2018), Vancouver, Canada, 17 May 2018

133. Cannabis: The Final Word, RISE 2018, organized the Behavioural and Neurosciences Academy of India, Goa, 11 May 2018

134. National Drug Use Survey: An Overview. Delivered at National Conference of Drug Law Enforcement agencies, 24 March 2018, New Delhi

135. Alcohol Use Disorder: Demand Reduction Strategies. Delivered at South East Asia Region course on Public Health Approaches for Non-Communicable Disease, 21 March 2018, New Delhi

136. Opioid Substitution Treatment: An Overview of Theory and Evidence Base, Workshop organized by National STD AIDS Control Program, Government of Sri Lanka, Colombo, 27 February 2018

137. An Overview of Drug Use Disorders. Training programme for Drug Law Enforcement officers from Government of Myanmar, Narcotics Control Bureaue, New Delhi, 23 February 2018

138. Pharmaceutical drug use – South Asia, training programme for officers from Department of Narcotics Control, Bangladesh, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 13 December 2017

139. Drug Use Epidemiology: Methodological Issues. Training Programme on “Advanced Sampling Techniques” for officers of Indian Statistical Service, National Statistical Systems Training Academy (NSSTA), Greater Noida, 7 Dec 2017

140. Co-morbid Cannabis Use Disorder and Gaming Disorder, Fourth WHO meeting on Public health Implications of Addictive Behaviors, Istanbul, Turkey, 1 December 2017

141. Trends in Drug Laws and Policies. National Conference of Addiction Psychiatry, AIIMS, New Delhi, 27 November 2017

142. Issues related to Pharmaceutical drugs Abuse, training programme for Drug Law enforcement officers from Tanzania, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 10 November 2017

143. Cannabis Dependence: Neurobiology and treatment approaches. Annual Conference of Indian Association for Biological Psychiatry, Chandigarh, 19 August 2017

144. Beyond Alcohol: Issues and Strategies, meeting of Indian Psychiatric Society, Bihar (in the wake of alcohol prohibition), Patna, 24 July 2017

145. Alcohol Control: Identifying opportunities for civil society action in the current policy context. National Civil Society Consultation on Non-Communicable Diseases (NCDs) in India, New Delhi, 11 July, 2017

146. Abuse of Pharmaceutical drugs, training programme for Drug Law enforcement officers, National Academy of Customs, Excise and Narcotics (NACEN), Faridabad, 31 May 2017

147. Do drug policies impede the availability of treatment of opioid dependence in India (and more so for non-injecting opioid users)? Analysis of epidemiological data from Punjab, India, International Society for the Study of Drug Policy Conference 2017 (ISSDP 2017), Aarhus, Denmark, 16 May 2017

148. Can economic analysis of household income and expenditure inform alcohol policies? Analysis of household data from nationally representative sample from India, International Society for the Study of Drug Policy Conference 2017 (ISSDP 2017), Aarhus, Denmark, 17 May 2017

149. Managing Pain in Palliative care with Opioids: Perspective of an Addiction Treatment Provider, Annual Conference on Indian Association of Palliative Care, Coimbatore, 11 February 2017

150. Alcohol and Public Health: Impact and Solutions. JJ Memorial oration on mental health, delivered at Govt. Grants Medical College, Mumbai, 24 January 2017

151. National Survey on Extent and Pattern of Substance Use in India: Methodology and Operational Issues, Annual National Conference of Indian Psychiatric Society, Raipur, 6 Jan 2017

10. Investigator/ Co-investigator in funded projects along with year completed/ongoing

As Principal Investigator:

1. National Survey on Extent and Pattern of Substance use in India, Supported by the Ministry of Social Justice and Empowerment, Government of India (2016-2021)

2. Development and evaluation of service delivery models for management of substance use disorders among the homeless population receiving urban shelter services in Delhi, Supported by the Department of Women and Child Development, Government of NCT of Delhi (2021 – ongoing)

3. Establishing Addiction Treatment Facilities in Government Health care settings, Supported by the Ministry of Social Justice and Empowerment, Government of India (2019-ongoing)

4. Field Testing of ICD-11 Classification for Disorders related to Substance Use and Addictive Behaviours, Supported by WHO (Geneva), (2018-2020)

5. Developing Training Mechanisms for use of Essential Narcotic Drugs (Methadone) for the treatment of Opioid Dependence, Supported by the Dept. of Revenue, Government of India (2017 – ongoing)

6. Effectiveness of the revised version of DrinkLess – A Web based self help intervention to reduce alcohol consumption in harmful hazardous drinkers: A Transnational RCT. Supported by World Health Organization (Geneva). (2016-ongoing)

7. Punjab Opioid Dependence Survey, supported by the Society for Promotion of Youth and Masses (SPYM), with financial support from Ministry of Social Justice and Empowerment, Government of India (2014 – 2015)

8. Development of an online training programme on Opioid Substitution Therapy, Project supported by Public Health Foundation of India (2014 – 2017)

9. Post Marketing Surveillance of Methadone in India, Project supported by the Rusan Pharma (2013 – 2014)

10. Drug Use Pattern Assessment in Bihar, Haryana and Uttarakhand, project supported by India HIV/AIDS Alliance and NACO (2013 – 2014)

11. Opioid Substitution Therapy under the National AIDS Control Program: A situation Assessment, supported by GFATM Round 9 grant and NACO, 2012

12. Risk of Transition to Injecting Drug Use among non-injecting opioid users: A Multi-site study in Northwest India, supported by Regional Resource Training Centre, MoSJE, Government of India (2012)

13. A pilot study of feasibility and efficacy of Brief intervention compared with Simple Advice when linked to the Brief ASSIST for Substance Use Disorders in Primary Health Care and Community Settings: Project of University of Adelaide, WHO Collaborating Centre, (2011)

As Co-Investigator:

1. Experience of Patients on Methadone Maintenance Treatment receiving Take-Home Methadone doses during COVID-19 pandemic In India: A mixed-method study. Investigators:Ravindra Rao, Atul Ambekar, Rakesh Chadda, Alok Agrawal, Roshan Bhad (2021 – ongoing)

2. Establishing and Implementing Capacity Building Mechanisms for Addiction Treatment Facilities in India Investigators: Alok Agrawal, Atul Ambekar, Rakesh Chadda, Roshan Bhad, Ravindra Rao, (2019-ongoing)

3. Field Testing of International Standards for Treatment of Drug Use Disorders, Investigators: Rakesh Chadda, Atul Ambekar, Roshan Bhad, Ravindra Rao, Alok Agrawal (2017 – 2019)

4. Rapid Assessment of Drug Use Patterns (RADUP) among People Who Use and/or Inject Drugs (PWUD/PWID) in Sri Lanka, Investigators: Sathya Herath, Atul Ambekar (2017-2018)

5. Mapping and size estimation of drug using street children in Delhi. Investigators: Anju Dhawan, Atul Ambekar, Ashwani Mishra, Rachna Bhargava, Biswadip Chatterjee, Alok Agrawal, 2015 – 2016

6. Workplace intervention for Drug and Alcohol use at Indian Oil Refinery, Digboi, Assam, Investigators: Prof Rajat Ray, Atul Ambekar, Rakesh Lal, Deepak Yadav (2010-ongoing)

7. Methadone Maintenance Treatment in India: A multi-site feasibility and effectiveness study. Investigators: Anju Dhawan, Atul Ambekar, Rajat Ray, Deepak Yadav, Anita Chopra, Raka Jain 2011 – 2014

8. OST program in Government health-care settings: treatment compliance and retention’, Investigators: Deepak Yadav, Atul Ambekar, Anju Dhawan, Alok Agrawal, Jyoti Mehra, Hem Sethi, report submitted to DFID TAST and NACO, Government of India

9. Mapping and size estimation of High Risk Groups in Jammu and Kashmir and Tripura, in collaboration with Society for Promotion of Youth and Masses, New Delhi, conducted for and report submitted to National AIDS Control Organisation (NACO), New Delhi, 2008

10. A Rapid situation assessment of inhalant use among street children in Delhi and development of an intervention, Investigators: Rajat Ray, Anju Dhawan, Atul Ambekar, Deepak Yadav, Anita Chopra, 2008-2009

11. Developing community-based drug treatment services at four districts in the country – Mandsaur, MP, Bilaspur, Chattisgarh, Meerut, UP and Morigaon, Assam, Investigators: Rajat Ray, Atul Ambekar, Rakesh Lal, Deepak Yadav, Anita Chopra, 2008-2013

11. Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing

12. Thesis supervised for MD/ DM/PhD

- as guide: 12

-as co-guide: 23

13. Awards and Honours

• Awarded, Meritorious Award for outstanding contribution for the prevention & control of Non-Communicable Diseases (NCDs), April 2022, National Resource Centre for Non- Communicable Diseases, Thiruvalla, Kerala and Alcohol and Drug Information Centre (ADIC)

• Awarded “Venus International Medical Award 2019 (VIMA 2019)” for Excellence in Psychiatry, April 2019

• Awarded “JJ Memorial Oration on Mental Health”: Govt. Grant Medical College, Mumbai, January 2017 (Topic- Alcohol and Public Health: Impact and Solutions)

• Winner of “BMJ Awards South Asia 2016” for the category, “Non-Communicable Disease Initiative of the Year”, November 2016

• Awarded Travel Grant (Scholarship) for the Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong (Oct 2019)

• Awarded Travel Grant (Scholarship) for the Annual Conference of International Society for the Study of Drug Policy, Sydney, Australia, May 2016

14. Any other relevant information:

Nominated member:

• Inter-Ministerial committee on 'dual use' and illicit trafficking of prescription drugs and precursors - Narcotics Control Bureau, Ministry of Home Affairs, Government of India (2022-ongoing)

• Expert Committee for Reviewing the Current Model for the Integrated Rehabilitation Centre for Addicts (IRCA) Under NAPDDR - Ministry of Social Justice and Empowerment, Government of India (2022-2023)

• Subject Expert Committee (Psychiatry and Neurology) – Central Drug Standards Control Organization, Ministry of Health and Welfare, Government of India (2017 - ongoing)

• Global Burden of Disease (GBD), India Mental Health Expert Group – Public Health Foundation of India(2017- ongoing)

• National Technical Resource Group, Injecting Drug Use - National AIDS Control Organisation, Government of India (2013 - ongoing)

• Project Selection Committee  for setting up of District De-Addiction Centres (DDACs) under National Action Plan for Drug Demand Reduction (NAPDDR) - Ministry of Social Justice and Empowerment, Government of India (2022-ongoing)

• Honorary Fellow, School of Criminology, University of Hong Kong (2019-ongoing)

• Expert committee on “Exploring the possibility of blocking of illicit use of ‘dual use’ precursor chemicals for the manufacture of narcotic drugs, psychotropic substances and new psychoactive substances”, - Ministry of Home Affairs, Government of India (2020-2021)

• National Consultative Committee on Drug Addiction and Rehabilitation - Ministry of Social Justice and Empowerment, Government of India (2015-2020)

• Expert Advisory Panel on Drug Dependence - World Health Organization (WHO), Geneva (2012 -2019)

• Strategic Advisory Group to United Nations, IDU and HIV - UNAIDS, UNODC and WHO (2012-2016)

• Chairperson, Addictive Disorders Speciality Section, Indian Psychiatric Society (2019-2021)

• Punjab Drug Addiction Rehabilitation Board, Government of Punjab, India (2018 - 2021)

• National Task Force for Integrating Mental Health in Comprehensive Primary Health Care – Ministry of health and Family Welfare, Government of India (2018-19)

• Steering Committee for Alcohol Control and Health – Ministry of Health and Family Welfare, Government of India (2014-2016)

• National Task Force on Drug Demand Reduction and Capacity Building –Ministry of Social Justice and Empowerment, Govt. of India (2011-12)

• Governing Body, Rajkumari Amrit Kaur College of Nursing, Delhi University (2021 - ongoing)

MEMBERSHIP OF PROFESSIONAL SOCIETIES:

• Addiction Psychiatry Society of India (APSI) – Secretary General

• American Society of Addiction Medicine (ASAM)

• Asia Pacific Society for Alcohol and Addiction Research (APSAAR) – Board of Directors (2017-21)

• Harm Reduction International (HRI)

• Indian Association for Social Psychiatry (IASP) – Elected Member, Executive Council (2017-20)

• Indian Association of Private Psychiatry (IAPP) – Member, National Advisory Board

• Indian Psychiatric Society (IPS) – Member, Certification and course committee

• International AIDS Society (IAS)

• International Doctors for Healthier Drug Policies (IDHDP)

• International Society for Substance Use Treatment & Prevention Professionals (ISSUP)

• International Society for the Study of Drug Policy (ISSDP)

• International Society of Addiction Medicine (ISAM) – Member, Board of Directors

MEMBERSHIP OF EDITORIAL AND ADVISORY BOARDS OF ACADEMIC JOURNALS:

• International Journal of Drug Policy

• International Journal of Mental Health and Addiction

• Journal of Addiction and Dependence

• Journal of HIV for Clinical and Scientific Research

• Journal of Drug Safety and Toxicology

• Journal of Mental Health and Human Behaviour

INTERNATIONAL CONSULTANCIES / EXPERT SERVICES

• Developing an online training program on ‘Unhealthy Substance Use’ for Primary Care Physicians (for the NCD Academy platform on Mental Health Disorders). Consultancy for World Psychiatric Association (WPA) and American College of Cardiology (ACC) (2021)

• Demonstration Project on Opioid Substitution with Buprenorphine at Myanmar. Community Partners International (with support from USAID and UNAIDS) (2019-ongoing)

• Drafting thematic chapter of INCB Annual Report 2017 (“Treatment & rehabilitation of drug use disorders: Essential component of demand reduction”). International Narcotics Control Board (INCB), Vienna (2017)

• Rapid Assessment of Drug Use Pattern in Sri Lanka. Alliance Regional Technical Support Hub South Asia and the National STD/AIDS Control Programme, Sri Lanka (2017-2018)

• Developing (a) “Standard Policy and Practice Guidelines” and “Training Manual” and (b) conducting training programmes for Counsellors. National Drug Law Enforcement Agency (NDLEA), Government of Nigeria and UNODC, Vienna (2015-2017)

• Review of Methodology and data on estimates of Injecting Drug Users and HIV service-coverage for World Drug Report 2014. UNODC, Vienna, (2013-2014)

• Developing a E-health portal on Problem alcohol use in India, [https://www.alcoholwebindia.in] WHO, Geneva (2010-13)

• National Drug Use Survey in Maldives.UNODC, Maldives Project Office (2011-2012)

• Capacity Building on Methadone Maintenance Treatment for service providers from Nepal and Bangladesh. UNODC, ROSA (2010)

• A Review of OST Programme of Nepal. UNODC, ROSA (2010)

NATIONAL CONSULTANCIES / EXPERT SERVICES

Training and Capacity Building Consultancies

• Developing training manual on Opioid Substitution Treatment (buprenorphine), under the National AIDS Control Programme, Govt. of India. (2021)

• Developing training manual on Methadone Maintenance Treatment, under the National AIDS Control Programme, Govt. of India. Emmanuel Hospital Association and National AIDS Control Organization, India (2015-2017)

• Induction training on OST under the National AIDS Control Programme for North Eastern states of India, UNODC, ROSA, (2012-2013)

• Training, Quality Assurance and Mentoring for OST in Government Heath care settings in Punjab. DFID-TAST andNACO, Government of India (2010 –2012)

• Capacity Building Needs Assessment (CBNA)andstudy ofFactors Influencing Performance of IDU Targeted Interventions in India. UNODC, ROSA, under GFATM Round 9 (2011)

• Developing a Training Manual for reaching out to female sex partners of male IDUs, and conducting TOT Programme.UNODC, ROSA (2010-2011)

• Developing a training manual for counsellors in the context of Injecting Drug Use – Targeted Intervention, Consultancy for UNODC, ROSA (2010-2011)

Research and Evaluation Consultancies

• Punjab Opioid Dependence Survey (PODS). Society for Promotion of Youth and Masses (SPYM), New Delhi (Ministry of Social Justice and Empowerment, Govt of India). 2014 – 2015

• Drug Use Pattern Assessment among People Who Inject Drugs (PWID) in Haryana, Bihar and Uttarakhand, India HIV/AIDS Alliance and NACO (2013-2014)

• Association of Drug Use pattern with Vulnerability and Service uptake among Injecting Drug Users in India, UNODC, ROSA, (2012)

• Gaps and Barriers in implementing and scaling up services for HIV Prevention among IDUs in Punjab and Haryana. UNODC, ROSA (2009)

• Size Estimation of Injecting Drug Use in Punjab and Haryana. UNAIDS, India (2007-08)

OTHER ACTIVITIES

• Represented Ministry of Health and Family Welfare, Government of India as a part of Indian delegation at the Indo-US Counter Narcotics Working Group (CNWG) meeting, New Delhi, July 2022

• Represented Ministry of Health and Family Welfare, Government of India as a part of Indian delegation at the Commission on Narcotic Drugs (CND), Vienna, Mar 2020, April 2021, March 2022, September 2022

• In-charge (and initiated): Women Substance Use Clinic (every Saturday) at NDDTC, AIIMS.

• In-charge (and initiated): Community Outreach Clinic, (focused on homeless substance users) Kotla Mubarakpur, New Delhi

• In-charge: Implementation of the scheme “Strengthening Drug De-Addiction Programme: Establishing Drug Treatment Clinics (DTCs)”, Ministry of Health and Family Welfare, Government of India. Details at: http://dtc-scheme.in/

• In-charge: Implementation of the scheme “Establishing Addiction Treatment Facilities (ATFs) in government hospitals in India”, Ministry of Social Justice and Empowerment, Government of India. Details at: https://atf-scheme.in/

• Organizing Secretary for the 1^st National Conference of Addiction Psychiatry Society of India (APSI) – ADDICON 2021, December 2021

• Organizing Secretary for the National CME, “Emerging Issues in Substance Use Disorders”, AIIMS, New Delhi, July 2017

• Organizing Secretary for the National CME, “Opioid Substitution Therapy: Policy and Practice”, AIIMS, New Delhi, April 2015

• Chairperson, Website & IT Committee for the Global congress of International Society of Addiction Medicine (ISAM 2019)

• Contributed towards developing the “Substance Use Treatment Unit (SUTU)” at AOD Hospital, Indian Oil Refinery, Digboi, Assam.